Navigation Links
Sunesis Pharmaceuticals' SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
Date:12/10/2007

monstrated 10- to 30-fold greater activity than that of flavopiridol in inhibiting transcription. Flavopiridol is a non-selective pan-CDK inhibitor currently in late-stage evaluation for the treatment of CLL.

Dr. Plunkett will present these data during this evening's poster session "CLL: Salvage Therapies and New Agents" from 5:00 p.m. to 7:00 p.m.

"SNS-032 demonstrates potent and selective induction of apoptosis in primary CLL cells at concentrations that we believe are achievable clinically. Data from these non-clinical studies of SNS-032 provide solid support and in vitro validation for our ongoing clinical trial of SNS-032 in patients with advanced CLL or multiple myeloma," said Dr. Adelman.

Conference Call Information

Sunesis management will host a conference call with clinical investigators discussing data presented today at the ASH meeting at 4:00 p.m. Eastern Time/1:00 p.m. Pacific Time.

Individual and institutional investors can access the call via 877-723-9519 (U.S. and Canada) or 719-325-4841 (international). To access the live audio webcast and subsequent archived recording, visit the "Investors and Media - Calendar of Events" section of the Sunesis website at http://www.sunesis.com. Please log on to Sunesis' website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary. A replay of the conference call will be archived on the Sunesis website for two weeks until December 24, 2007.

About Sunesis' Oncology Programs

Sunesis has built a rich portfolio of product candidates in oncology focused on novel pathways and targets, including inhibition of the cell-cycle and survival signaling. SNS-595, a first-in-class naphthyridine analog that intercalates DNA and poisons topoisomerase II causing selective DNA damage, is currently in a Phase 1b clinical trial in patients with acute leukemia and a
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... 31, 2015 , ... Healthpointe , a multidisciplinary health ... at Healthpointe.net. The new website will feature a sleek and streamlined design built ... provide smoother interactions between patients and the Healthpointe clinics and ensures that appointments ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... Karmanos Center for Natural Birth . The Karmanos Center for Natural ... natural childbirth experience. With nurses and caregivers that are trained in holistic birth ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... 100% organic, natural, therapeutic-grade oils from ingredients sourced all over the world, then ... “With considerable effort, we have developed the highest-quality oils in the industry, which ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Super-Sod wants to ... a Super-Sod Pro Page as the perfect fit for such a goal. ... and articles. The social website is a dynamic site that spreads home and home ...
(Date:7/31/2015)... FL (PRWEB) , ... July 31, 2015 , ... ... the United States for temporary work, study or family visit for the past 25 ... their 80s and 90s are able to travel and spend time with their children ...
Breaking Medicine News(10 mins):Health News:Healthpointe Announces Newly Redesigned Website 2Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 3
... human donor eyes provided for ophthalmology research by U.S. ... ophthalmology// , according to an article published in the ... ,“Nowhere do impediments to obtaining human eyes for research ... age-related macular degeneration, the leading cause of new vision ...
... of high-use drugs released from eight sewage treatment ... plants// in the aquatic receiving environment are unlikely. ... of Environmental Toxicology and Chemistry. ,The ... of drugs is increasing to match its demand ...
... far northern South Africa turn to nature when seeking to ... emerged in news reports//. ,The root of the wild ... Venda district near the Kruger National Park along the border ... ,The compound extracted from its root and consumed with tea ...
... taking due precaution following reports of suspected dengue fever ... the blood sample// of the affected being sent for ... shown symptoms of Dengue fever and we have sent ... the reports," KDMC run Municipal hospital doctor Sanjeev Kamble ...
... doctor in Gujarat claims he has pioneered a technique ... not only overcomes the problem of organ rejection// but ... world have been grappling with the problem of rejection ... this situation, patients are given strong immunosuppressants that leave ...
... health chief to give leadership and implement the ambitious global ... a British expert//. ,"If we are going to ... India to eradicate tooth caries problem among children in the ... Professor Raman Bedi, director of the global taskforce. ,"We ...
Cached Medicine News:Health News:Indian doctor's new stem cells technique for kidney transplant 2Health News:India needs dental health leadership, says expert 2Health News:India needs dental health leadership, says expert 3
(Date:7/31/2015)... 2015 Magnaquest, a leading ... and cloud computing operators has signed a Proof ... for Internet of Things (IoT) related initiative. The ... subscription model.      (Logo: http://photos.prnewswire.com/prnh/20140807/700645 ... for business innovations to make healthcare services more ...
(Date:7/30/2015)... July 30, 2015  ResMed (NYSE: ... a definitive agreement to acquire Curative Medical, ... and sleep-disordered breathing medical devices and accessories. ... in China, combined with ResMed,s global leadership in sleep and respiratory ... China suffering from sleep-disordered ...
(Date:7/30/2015)... DIEGO , July 30, 2015  Tandem ... medical device company and manufacturer of the t:slim® ... has entered into non-exclusive Development Agreements with Dexcom, ... Tandem insulin pumps with the Dexcom G5 and ... "Integrating Tandem,s next generation pump platform with Dexcom,s ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... an Interventional Radiology Treatment -- Detailed for Those ... Osteoplasty -- a highly effective minimally invasive procedure ... disease by injecting bone cement to support weakened ... often presenting individuals who are suffering terribly with ...
... Any Age: Comparison by Interventional Radiologists Shows No ... FistulasSAN DIEGO, March 9 A new study ... disease, it doesn,t matter if you,re young or ... for maintaining access to one,s circulatory system to ...
Cached Medicine Technology:Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 2Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 3Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 4Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 5For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 2For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 3For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 4
Inquire...
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
Inquire...
... Scientific PSE Power Supply . The digital ... V and 2 A in 1 volt and ... run up to three SEA 2000® apparatus simultaneously ... preset and actual values of voltage, current and ...
Medicine Products: